NeoGenomics acquires lab

FORT MYERS — Cancer-testing firm NeoGenomics acquired Path Labs for $6 million, diversifying its laboratory services.

The transaction includes Path Logic's main laboratory in West Sacramento, Calif., as well as satellite facilities in Santa Ana and Fresno, Calif. Path Logic will operate as a subsidiary of NeoGenomics to provide specialized anatomic pathology services for clinical trials and pathology clients across the country.

“Path Logic has earned a reputation as one of the highest quality anatomic pathology laboratories in California,” says Douglas VanOort, NeoGenomics chairman and CEO, says in a statement. “With this expanded capability, both our clinical trial clients and our hospital and pathology-based clients will have access to an expanded product line and consulting expertise.”